Kulveer Mankia (K Mankia)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 33

Top Topics

Rheumatoid Arthritis

Monoclonal Antibody

Disease Activity

Top Venues

Annals of the rheumatic diseases

Rheumatology advances in practice

The British journal of general practice : the journal of the Royal College of General Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin D Deane, V Michael Holers, Paul Emery, Kulveer Mankia, Hani El Gabalawy, Jeffrey A Sparks, Karen H Costenbader, Larissa Valor-Méndez, Annette van der Helm-van Mil, Dirkjan van Schaardenburg, Ranjeny Thomas, Andrew P Cope
Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease. Annals of the rheumatic diseases (2024)
Andrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, Sana Sharrack, Laurence Duquenne, Jacqueline L Nam, Michael Mahler, Paul Emery
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD open 10 (2) (2024)
Andrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, Sana Sharrack, Laurence Duquenne, Jacqueline L Nam, Michael Mahler, Paul Emery
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD open 10 (2) (2024)
Lara S Chapman, Heidi J Siddle, Stefan Serban, Kulveer Mankia, Christopher M Rooney, Zhain Mustufvi, Simon Pini, Karen Vinall-Collier
'What is my risk really?': a qualitative exploration of preventive interventions among individuals at risk of rheumatoid arthritis. Rheumatology advances in practice 8 (2) (2024)
Andrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, Sana Sharrack, Laurence Duquenne, Jacqueline L Nam, Michael Mahler, Paul Emery
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD open 10 (2) (2024)
Lara S Chapman, Heidi J Siddle, Stefan Serban, Kulveer Mankia, Christopher M Rooney, Zhain Mustufvi, Simon Pini, Karen Vinall-Collier
'What is my risk really?': a qualitative exploration of preventive interventions among individuals at risk of rheumatoid arthritis. Rheumatology advances in practice 8 (2) (2024)
Andrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, Sana Sharrack, Laurence Duquenne, Jacqueline L Nam, Michael Mahler, Paul Emery
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD open 10 (2) (2024)
Andrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, Sana Sharrack, Laurence Duquenne, Jacqueline L Nam, Michael Mahler, Paul Emery
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD open 10 (2) (2024)
Heidi J Siddle, Stephen Henry Bradley, Anna M Anderson, Kulveer Mankia, Paul Emery, Suzanne H Richards
Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice. The British journal of general practice : the journal of the Royal College of General Practitioners 73 (729) (2023)
Innocent Chidi Anioke, Laurence Duquenne, Rekha Parmar, Kulveer Mankia, Farag Shuweihdi, Paul Emery, Frederique Ponchel
Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals. Rheumatology (Oxford, England) (2023)
Lara S Chapman, Karen Vinall-Collier, Heidi J Siddle, Zhain Mustufvi, Kulveer Mankia, Stefan Serban
'It surprised me a lot that there is a link': a qualitative study of the acceptability of periodontal treatment for individuals at risk of rheumatoid arthritis. RMD open 9 (2) (2023)
Heidi J Siddle, Stephen Henry Bradley, Anna M Anderson, Kulveer Mankia, Paul Emery, Suzanne H Richards
Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice. The British journal of general practice : the journal of the Royal College of General Practitioners 73 (729) (2023)
Lara S Chapman, Karen Vinall-Collier, Heidi J Siddle, Zhain Mustufvi, Kulveer Mankia, Stefan Serban
'It surprised me a lot that there is a link': a qualitative study of the acceptability of periodontal treatment for individuals at risk of rheumatoid arthritis. RMD open 9 (2) (2023)
Heidi J Siddle, Stephen Henry Bradley, Anna M Anderson, Kulveer Mankia, Paul Emery, Suzanne H Richards
Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice. The British journal of general practice : the journal of the Royal College of General Practitioners 73 (729) (2023)
Bernard H van Duren, Alice Wignall, Susan M Goodman, Catherine Elizabeth Hewitt, Kulveer Mankia, Hemant G Pandit
The Effect of Perioperative Biologic Disease-Modifying Anti-Rheumatic Drugs on the Risk of Postoperative Complications: Surgical Site Infection, Delayed Wound Healing, and Disease Flares Following Orthopaedic Surgical Procedures. The Journal of bone and joint surgery. American volume 104 (12) (2022)
Frederique Ponchel, Laurence Duquenne, Xuanxiao Xie, Diane Corscadden, Farag Shuweihdi, Kulveer Mankia, L A Trouw, Paul Emery
Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals. RMD open 8 (2) (2022)
Frederique Ponchel, Laurence Duquenne, Xuanxiao Xie, Diane Corscadden, Farag Shuweihdi, Kulveer Mankia, L A Trouw, Paul Emery
Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals. RMD open 8 (2) (2022)
Frederique Ponchel, Laurence Duquenne, Xuanxiao Xie, Diane Corscadden, Farag Shuweihdi, Kulveer Mankia, L A Trouw, Paul Emery
Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals. RMD open 8 (2) (2022)
Zhain Mustufvi, Joshua Twigg, Joel Kerry, James Chesterman, Sue Pavitt, Aradhna Tugnait, Kulveer Mankia
Does periodontal treatment improve rheumatoid arthritis disease activity? A systematic review. Rheumatology advances in practice 6 (2) (2022)
Christopher M Rooney, Kulveer Mankia, Suparna Mitra, Ines B Moura, Paul Emery, Mark H Wilcox
Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis. Rheumatology (Oxford, England) 60 (7) (2021)
Fenne Wouters, Marc P Maurits, Laurette van Boheemen, Marloes Verstappen, Kulveer Mankia, Xanthe Marijn Edmée Matthijssen, Annemarie L Dorjée, Paul Emery, Rachel Knevel, Dirkjan van Schaardenburg, René E M Toes, Annette H M van der Helm van Mil
Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis. Annals of the rheumatic diseases (2021)
Heidi J Siddle, Lara S Chapman, Kulveer Mankia, Codruța Zăbălan, Marios Kouloumas, Karim Raza, Marie Falahee, Joel Kerry, Andreas Kerschbaumer, Daniel Aletaha, Paul Emery, Suzanne H Richards
Perceptions and experiences of individuals at-risk of rheumatoid arthritis (RA) knowing about their risk of developing RA and being offered preventive treatment: systematic review and thematic synthesis of qualitative studies. Annals of the rheumatic diseases (2021)
Kulveer Mankia, Heidi Siddle, Andrea Di Matteo, Deshiré Alpizar-Rodriguez, Joel Kerry, Andreas Kerschbaumer, Daniel Aletaha, Paul Emery
A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. RMD open 7 (3) (2021)
Bernard H van Duren, Alice Wignall, Amar Rangan, Laura C Coates, Hemant Pandit, Kulveer Mankia
To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery? Rheumatology advances in practice 5 (3) (2021)
Kulveer Mankia, Heidi J Siddle, Andreas Kerschbaumer, Deshiré Alpizar-Rodriguez, Anca Irinel Catrina, Juan D Cañete, Andrew P Cope, Claire Immediato Daien, Kevin D Deane, Hani El Gabalawy, Axel Finckh, V Michael Holers, Marios Koloumas, Francesca Ometto, Karim Raza, Condruta Zabalan, Annette H M van der Helm van Mil, Dirkjan van Schaardenburg, Daniel Aletaha, Paul Emery
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. Annals of the rheumatic diseases 80 (10) (2021)
Andrea Di Matteo, Kulveer Mankia, Jacqueline L Nam, Edoardo Cipolletta, Leticia Garcia-Montoya, Laurence Duquenne, Emma Rowbotham, Paul Emery
In anti-CCP+ at-risk individuals, radiographic bone erosions are uncommon and are not associated with the development of clinical arthritis. Rheumatology (Oxford, England) 60 (7) (2021)
Andrea Di Matteo, Kulveer Mankia, Laurence Duquenne, Edoardo Cipolletta, Richard J Wakefield, Leticia Garcia-Montoya, Jacqueline Leong Nam, Paul Emery
Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis. Annals of the rheumatic diseases 79 (7) (2020)
Zijian Cheng, Thuy Do, Kulveer Mankia, Josephine Meade, Laura Hunt, Val Clerehugh, Alastair Speirs, Aradhna Tugnait, Paul Emery, Deirdre Ann Devine
Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis. Annals of the rheumatic diseases 80 (2) (2020)
Andrea Di Matteo, Kulveer Mankia, Richard J Wakefield, Paul Emery
Which joints and what pathological findings should be evaluated on ultrasound in CCP+ at-risk individuals? The fifth MTP joint for bone erosions is a good starting point. Response to: 'Pisotriquetral arthritis: 'forgotten' joint in ultrasound imaging of the wrist' by Becciolini et al. Annals of the rheumatic diseases (2020)
Graham Fent, Kulveer Mankia, Bara Erhayiem, Laura Hunt, Jacqueline Leong Nam, Lesley-Anne Bissell, James Rj Foley, Pei G Chew, Louise E Brown, John P Greenwood, Paul Emery, Sven Plein, Maya H Buch
First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis. Annals of the rheumatic diseases 78 (8) (2019)
Kulveer Mankia, Christopher Briggs, Paul Emery
How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies-positive Patients Who Do Not Have Arthritis? The Journal of rheumatology 47 (2) (2019)
Kulveer Mankia, Maria-Antonietta D'Agostino, Emma Rowbotham, Elizabeth Ma Hensor, Laura Hunt, Ingrid Möller, Misabel Miguel, José Ramon Mérida-Velasco, Jorge Murillo-González, Esperanza Naredo, Jacqueline Leong Nam, Ai Lyn Tan, Jane E Freeston, Andrew Grainger, Paul Emery
MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis. Annals of the rheumatic diseases 78 (6) (2019)
Kulveer Mankia, Maria-Antonietta D'Agostino, Jorge Murillo-González, Andrew Grainger, Paul Emery
Response to: 'Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?' by Deng et al. Annals of the rheumatic diseases 79 (7) (2019)